In addition to pneumococcal disease,
Haemophilus influenzae type b (Hib), is a second leading cause of pneumonia. By the end of 2012, nearly all GAVI-eligible countries will have introduced the
Hib vaccine with GAVI support, immunising a cumulative 120 million children.
